Hospital Pharmacy - May 2017 - 366

366

2.
3.
4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

Hospital Pharmacy 52(5)
apps.who.int/iris/bitstream/10665/67378/1/WHO_EDM_
QSM_2002.2.pdf. Published 2002. Accessed June 7, 2017.
Moore TJ, Psaty BM, Furberg CD. Time to act on drug safety.
JAMA. 1998;279(19):1571-1573.
Saha L. Role of pharmacovigilance in drug development.
Enliven Pharmacovigil Drug Saf. 2014;1(1):9-10.
Ponmari SJ, Sivaraman M, Aruna T, Subashree V. Knowledge
and awareness of pharmacovigilance among various medical
fraternities. Asian J Pharmacol Toxicol. 2015;03(10):45-48.
Vallano A, Cereza G, Pedròs C, et al. Obstacles and solutions
for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol. 2005;60(6):653-658.
Hohl CM, McGrail K, Sobolev B. The effect of pharmacistled medication review in high-risk patients in the emergency department: an evaluation protocol. CMAJ open. 2015
Jan;3(1):E103.
Aziz Z, Siang TC, Badarudin NS. Reporting of adverse
drug reactions: predictors of under-reporting in Malaysia.
Pharmacoepidemiol Drug Saf. 2007;16(2):223-228.
Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ.
Physicians' attitudes and adverse drug reaction reporting: a
case-control study in Portugal. Drug Saf. 2005;28(9):825-833.
Generali JA, Danish MA, Rosenbaum SE. Knowledge of and
attitudes about adverse drug reaction reporting among Rhode
Island pharmacists. Ann Pharmacother. 1995;29(4):365-369.
Valente S, Murray L, Fisher D. Nurses improve medication
safety with medication allergy and adverse drug reports. J Nurs
Care Qual. 2007;22(4):322-327.
Ahmad A, Patel I, Balkrishnan R, Mohanta GP, Manna PK. An
evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: a pilot study.
Perspect Clin Res. 2013;4(4):204-210.
Taché SV, Sönnichsen A, Ashcroft DM. Prevalence of adverse
drug events in ambulatory care: a systematic review. Ann
Pharmacother. 2011;45(7-8):977-989.
Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc.
1996;41(2):192-199.
Jericho BG, Tassone RF, Centomani NM, et al. An assessment
of an educational intervention on resident physician attitudes,
knowledge, and skills related to adverse event reporting. J
Grad Med Educ. 2010;2(2):188-194.

15. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug
reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200-1205.
16. Qassim S, Metwaly Z, Shamsain M, Al Hariri Y. Reporting
adverse drug reactions: evaluation of knowledge, attitude
and practice among community pharmacists in UAE. IOSR J
Pharm. 2014;4(4):17-23.
17. Li Q, Zhang S, Chen H, et al. Awareness and attitudes of
healthcare professionals in Wuhan, China to the reporting of
adverse drug reactions. Chin Med J (Engl). 2004;117(6):856861.
18. Hardeep Bajaj JK, Rakesh K. A survey on the knowledge, attitude and the practice of pharmacovigilance among the health
care professionals in a teaching hospital in northern India. J
Clin Diagn Res. 2013;7(1):97-99.
19. McLernon DJ, Bond CM, Lee AJ, et al. Patient views and
experiences of making adverse drug reaction reports to the
Yellow Card Scheme in the UK. Pharmacoepidemiol Drug
Saf. 2011;20(5):523-531.
20. Okezie EO, Olufunmilayo F. Adverse drug reactions reporting
by physicians in Ibadan, Nigeria. Pharmacoepidemiol Drug
Saf. 2008;17:517-522.
21. Suyagh M, Farah D, Abu Farha R. Pharmacist's knowledge, practice and attitudes toward pharmacovigilance and
adverse drug reactions reporting process. Saudi Pharm J.
2014;23(2):147-153.
22. Hazell L, Cornelius V, Hannaford P, Shakir S, Avery AJ. How
do patients contribute to signal detection? a retrospective
analysis of spontaneous reporting of adverse drug reactions
in the UK's yellow card scheme. Drug Saf. 2013;36(3):199206.
23. Parretta E, Rafaniello C, Magro L, et al. Improvement of
patient adverse drug reaction reporting through a community
pharmacist-based intervention in the Campania region of Italy.
Expert Opin Drug Saf. 2014;13(suppl 1):S21-S29.
24. Vessal G, Mardani Z, Mollai M. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in
Iran. Pharm World Sci. 2009;31:183-187.
25. Van Grootheest AC, de Jong-van den Berg LTW. The role of
hospital and community pharmacists in pharmacovigilance.
Res Social Adm Pharm. 2005;1(1):12-33.
http://apps.who.int/iris/bitstream/10665/67378/1/WHO_EDM_QSM_2002.2.pdf http://apps.who.int/iris/bitstream/10665/67378/1/WHO_EDM_QSM_2002.2.pdf
Table of Contents for the Digital Edition of Hospital Pharmacy - May 2017
